Contrasting the phospholipid profiles of two neoplastic cell lines reveal a high PC:PE ratio for SH-SY5Y cells relative to A431 cells

Biochem Biophys Res Commun. 2023 May 14:656:23-29. doi: 10.1016/j.bbrc.2023.03.017. Epub 2023 Mar 14.

Abstract

Lipids have been implicated in Parkinson's Disease (PD). We therefore studied the lipid profile of the neuroblastoma SH-SY5Y cell line, which is used extensively in PD research and compared it to that of the A431 epithelial cancer cell line. We have isolated whole cell extracts (WC) and plasma membrane (PM) fractions of both cell lines. The isolates were analyzed with 31P NMR. We observed a significant higher abundance of phosphatidylcholine (PC) for SH-SY5Y cells for both WC (55 ± 4.1%) and PM (63.3 ± 3.1%) compared to WC (40.5 ± 2.2%) and PM (43.4 ± 1.3%) of A431. Moreover, a higher abundance of phosphatidylethanolamine was detected for the WC of A431 compared to the SH-SY5Y. Using LC-MS/MS, we also determined the relative abundance of fatty acid (FA) moieties for each phospholipid class, finding that SH-SY5Y had high polyunsaturated FA levels, including arachidonic acid compared to A431 cells. When comparing our results to reported compositions of brain and neural tissues, we note the much higher PC levels, as well as very low levels of docosahexaenoic acid. However, relative levels of arachidonic acid and other polyunsaturated fatty acids were elevated, in line with what is desirable for a neural model system.

Keywords: LC-MS/MS; Lipidomics; NMR; PC/PE ratio; Plasma membrane; SH-SY5Y.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arachidonic Acid
  • Cell Line, Tumor
  • Chromatography, Liquid
  • Fatty Acids, Unsaturated
  • Humans
  • Neuroblastoma* / metabolism
  • Phosphatidylcholines
  • Phospholipids*
  • Tandem Mass Spectrometry

Substances

  • Phospholipids
  • Phosphatidylcholines
  • Fatty Acids, Unsaturated
  • Arachidonic Acid